The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy's Cancer Centre.
Beth RussellCharlotte MossEirini TsotraCharalampos GousisDebra JosephsDeborah EntingChristina KaramperaMuhammad KhanJose RocaAilsa Sita-LumsdenKasia OwczarczykHarriet WylieAnna HaireDaniel SmithKamarul ZakiAngela SwampillaiMary LeiVishal ManikVasiliki MichalareaRebecca S KristeleitAnca MeraElinor SawyerLucy FlandersIrene De FrancescoSophie PapaPaul RossJames SpicerBill DannVikash JogiaNisha ShaunakHartmut KristeleitAnne RiggAna MontesMieke Van HemelrijckSaoirse DollyPublished in: Cancers (2022)
These real-world data from a tertiary Cancer Centre suggest that despite the challenges faced due to the COVID-19 pandemic, SACT was able to be continued without any significant effects on the mortality of solid-tumour patients. There was a low rate (2%) of SARS-CoV-2 infection which is comparable to the 1.4%-point prevalence in our total cancer population.